当前位置:药药网 / 药品研发 / 美国药品上市后承诺数据库
AUDENZ, Influenza A (H5N1) Monovalent Vaccine, Adjuvanted
药品名称
AUDENZ, Influenza A (H5N1) Monovalent Vaccine, Adjuvanted
承诺描述
To conduct a study (V130_12) to evaluate the efficacy, safety and immunogenicity of Flucelvax Quadrivalent compared to a non-influenza comparator vaccine in persons 4 years to less than 18 years of age.